22nd Century Group Inc (NASDAQ:XXII)

3.04
Delayed Data
As of Sep 17
 -0.06 / -1.94%
Today’s Change
0.56
Today|||52-Week Range
6.07
+38.18%
Year-to-Date
22nd Century Group (Finally) Unveils Its Third Business
Sep 15 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close3.10
Today’s open3.10
Day’s range3.03 - 3.15
Volume61,994
Average volume (3 months)2,321,761
Market cap$525.6M
Data as of 4:00pm ET, 09/17/2021

Growth & Valuation

Earnings growth (last year)+32.94%
Earnings growth (this year)-21.43%
Earnings growth (next 5 years)--
Revenue growth (last year)+8.82%
P/E ratioNM
Price/Sales10.86
Price/Book10.18

Competitors

 Today’s
change
Today’s
% change
ALDXAldeyra Therapeutics...+0.02+0.23%
VSTMVerastem Inc+0.07+2.59%
XBITXBiotech Inc+0.31+1.98%
AUTLAutolus Therapeutics...+0.11+1.67%
Data as of 4:00pm ET, 09/17/2021

Financials

Next reporting dateNovember 11, 2021
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$28.1M
Annual profit (last year)-$19.7M
Net profit margin-70.12%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Buffalo, New York

Forecasts